Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Ovarian Cancer
NCT00281632Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
pazopanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00281632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281632.